ABOUT US
Our story
the radically accessible solution for Children's Cognitive Health
Every child has the right to grow up to find their wings. Each and every child. The reality is, over 93% are left behind.
The pandemic, late diagnosis, lack of financial support, or simply because they were born in a country with insufficient medical infrastructure.
We are here to solve this problem.
A word from DoBrain's founder, Yejin Choi
High Tech, High Touch
"DoBrain was established to share and spread the expertise of 'appropriate medical care and education' through technology. We closely analyze the input data generated by children with high tech AI-based methodologies. This is used to provide accessible solutions that enable frequent engagement. (High touch)
Meet our set of innovative digital tools that empower clinicians, psychologists, teachers, therapists and caregivers to unleash the potential in every child. Welcome to the digital age of early intervention."
How it all started
DoBrain started 9 years ago as a volunteer program operating in low-income neighborhoods. Refugees and child abuse victims were our first students. We discovered these young children were suffering from cognitive delay due to numerous developmental issues.
However, the 100 dollar price-tag on private therapy was out of their reach. In collaboration with clinicians and neuroscientists, we initially created and provided DoBrain as a free cognitive treatment program. The class of 3 in 2013 grew to 683 in 2016, and demand kept growing. We soon needed a better way to reach these children. We turned to technology, and began our ambitious journey to transform the lives of children around the world.
Over 3 years,
600K+
Children Treated Worldwide
This month,
92%+
Monthly
Retention
More than
11
clinical trials completed
and ongoing
In series A,
11M
Raised in funding
and Grant
Development
Diagnosis AI Achieved
92.98%
maximum AUC
What our supporters say about us
SVP of Samsung Ventures
Il Seok Yoon
"As pandemic-driven anxiety and depression continue to impact mental health, the importance of digital therapeutics (DTx) is higher than ever. The defining benefits of DTx are direct access to patients, decrease in cost of treatment, encouragement of healthy lifestyles, and the ability to substitute or complement conventional treatments.
DoBrain's educational app for children with developmental disabilities marks the start of a great tide of events. We are confident that DoBrain, with its revolutionizing technology, will become a major player in the DTx industry as it expands to address the full array of cognitive indications. We are very proud to invest in this great company and look forward to accompanying DoBrain’s continued growth journey. "
CEO of Kilm Ventures
Hongkyu Nam
"There are many ways anyone can make money. However, the opportunity to do something meaningful in life is not so common. DoBrain is creating something beautiful, for the well-being and happiness of children around the world. Among all the teams I've met to this day, their vision is the most powerful."
Our Progress
[ Core Areas ]
Diagnosis, Treatment, Education
2017
Launched DoBrain app ver. 1.0
- No.3 Educational app on Google Play
- No.1 Free children's app on App Store
- Achieved 10K+ users within 3 months
Developed Cognitive Development Diagnosis AI ver. 1.0
Excellence Award, Asia Social Venture Competition
2018
Completed Phase 1 RCT Clinical Test at Asan Hospital
MOU with HAPTIC Center, Yonsei Medical School
MOU with National Pediatric Hospital, Cambodia
Launched cognitive improvement program in for the first time in Cambodia with KOICA CTS
Received seed funding from Spring Camp (Affiliate of Naver)
Awarded in Start Jerusalem 2018
2019
Completed Phase 2 RCT Clinical Test at Asan Hospital
Published AMIA poster on Clinical test results showing D-KIT effectiveness on cognitive development
Reached 400K+ users
Reached max AUC 92.98% for AI Diagnosis Algorithm with Yonsei Medical School
- Published in JMIR
Selected as C-LAB startup by Samsung Electronics
Selected as Top 7 by investors at Masschallenge
Finalist at Extreme Tech Challenge (XTC)
2020
Completed Clinical Tests at Severance Hospital
Completed joint clinical research at Cambodia National Pediatric Hospital and Yonsei Medical School
Enhanced AI algorithm with Yonsei Medical school to differentiate between various developmental disabilities
- Published in JMIR
Launched new educational model, DobrainEDU (D2C app)
- Monthly sales passed 100 million KRW mark (85K USD)
Nominated Asia 30 under 30 for Healthcare & Science
2021
Completed Phase 3 RCT Clinical Test at Asan Hospital
Reached 600K+ users globally
Completed clinical trials for mobile-based Child ESDM program at Gachon University College of Medicine
- D-2A, our product designed for autistic children
Started clinical tests on social skill game for ASD children
- D-4A, our product designed for high-functioning ASD children
Designing AI-based cognitive diagnosis algorithm to replace the Weschler test
Achieved 100 million KRW daily sales of DobrainEDU (85K USD)
Nominated as Tech Pioneer by World Economic Forum